Download
1 / 15
150 likes | 297 Views
Laboratory RFP Q & A session. Simon Everitt / Joy Cooper Planning and Funding 18 th August 2006. Overview of Process to date. Consultation on options for Lab-April 2005 Board decision to go out to RFP-May 2005 Delays due to Commerce Commission Planning and Development of RFP-Feb 06
E N D
Laboratory RFP Q & A session Simon Everitt / Joy Cooper Planning and Funding 18th August 2006
Overview of Process to date • Consultation on options for Lab-April 2005 • Board decision to go out to RFP-May 2005 • Delays due to Commerce Commission • Planning and Development of RFP-Feb 06 • Draft RFP consultation –May 2006 • Final RFP released -31 July 2006 • Closing of RFP-31 August 2006
DHBs Objectives Objectives for Laboratory Services WDHB: • Best possible health outcomes for Wairarapa residents • Efficient results, advice & support for best practice clinical decision making • Integrated service spanning primary and secondary care • Clinically and financially viable • Works collaboratively with other services/stakeholders.
Overview of RFP RFP-Part 1-Key Points to Note Section A: Overview & Background • DHB and Board Objectives and vision (5) & (10) • Current providers of laboratory services Section B: Probity, Timelines & Terms • Engaged a Probity Auditor to oversee process (26) • Probity Plan-ensure good and robust process • Contract period – 5 years and 5 months 1 February 2007-30 June 2012 (34) • Fixed price proposals covering all laboratory testing (35) Section C: RFP Requirements • 14 copies due 31st August 2006-non price information • Separate copy due 31 August 2006-price information (42-46) • 22 August 2006 last day for additional information & clarifications (50) • No canvassing-clarification has been provided (55)
Overview of RFP RFP-Part 1-Key Points to Note continued Section D: RFP Conditions • All information provided is confidential both ways (78) • Must meet your own costs in preparing and submitting you proposal (79) • WDHB may require Ministerial Approval to any service change Section E: Evaluation • Completing due diligence on RFP responses IT/clinical/financial 1-12th September 2006 (96) • Stage 1: evaluate ability to provide an effective service/collaborative relationships and demand management/reporting/strategic fit • Assessed individually and as a panel to agree a common assessment • Criteria and weighting applied • If score 50 or more and have IANZ accreditation the provider proceeds to the second stage (90)
Overview of RFP RFP-Part 1-Key Points to Note continued • Stage 2: value for money and price-cash flows based on year 1-5 prices and total cost to the DHB (91) • WDHB may hold discussion/negotiations with one or more proposers. Section F: Notification • Notified in writing either way • Can be short listed but not preferred • Preferred provider does not constitute acceptance or create a contract.
Overview of RFP Appendices Appendix 2: Wai-Aro information • Facility lease $75k PA (draft provided) • Equipment can be purchased for $217,640 or leased for $78k PA • Organisational structure and staffing costs Appendix 6: Price form and costing • 1 fixed price (service fee) for all tests over 5 years • Costing breakdowns and assumptions required Appendix 7: Service & Quality Specification • Questions from the floor
Overview of RFP Appendix 8,9,10:Tests Splits ID 3 categories of tests: • Community Referred Schedule Tests • Community referred Non Scheduled Tests • Hospital Referred Tests (IP & OP). Split in reporting to fit with HealthPAC national data collections.
Laboratory Data Three components: • Wai-Aro test volumes-inpatients and outpatients • Community Referred Non Schedule Tests • Community Referred Schedule Tests
Laboratory Data Issues: • No standardisation of test types • Different ways of counting tests • Different funding/purchasing arrangements • Variable availability of test information
Laboratory Data Community Referred Test Volumes Issues: • WDHB is not a Funder DHB in lab warehouse • WDHB does not contract with 2 providers in the region • WDHB has more IDF volumes out of region c.f. other regional DHBs Solutions: • Applied same methodology used by other DHBs • Accessed data directly from lab warehouse • Identified laboratory tests originating from the Wairarapa region • DHB of Domicile (93) is equal to: • 1. The DHB of patient if reported in the warehouse. If not reported then, • 2. The DHB of referrer if reported in the warehouse. If not reported then, • 3. The DHB of laboratory.
Laboratory Data Risks… Potential for the Funder to over state community referred test volumes But… Funder is responsible for total lab test costs whether through IDFs or local contracts And… Majority of volumes are referred by local primary care providers (82% % 70%).
Further information we have released • Canvassing clarification (3/8/2006) • Questions and Answers x 2 (11/8/2006 & 15/8/2006) • Minutes, ISSP for IT Q & A (11/8/2006) • Population Projections (15/8/2006) All information has been provided electronically and is available on the WDHB website.
